Stockreport

Postherpetic Neuralgia Market to Accelerate Significantly at a CAGR of 14% by 2034 | DelveInsight [Yahoo! Finance]

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF and the anticipated launch of novel therapies during the forecasted period (2024–2034). LAS VEGAS June 10, 2024 /PRNewswire/ -- DelveInsight's Postherpetic Neuralgia M [Read more]